Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects With Heart Failure

NCT03759392 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

276

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure With Reduced Ejection Fraction

Interventions

DRUG: Omecamtiv Mecarbil
DRUG: Placebo

Sponsor

Cytokinetics